Mate, plz stop promting the picture portrayed by the BIT management. The more you engaeg with footy and gy, the more ugly picure will come out. They (management onward) literally kept everyone in the dark in the name of commercial in confidence. Where are the final results analyses? Did they mention how much they'd paid to C14? Expected deadline for an outcome? They have deadline for money collection, but no deadline for any tangible outcome. How could they remain silent when they had opportuntiy exercise the options and rasie money when there were some good moments. How could they expect C14 would bring something before they got up from sleep with the PN that there'd be a shortage of funds? They mention a partnership and at the same time to be tricky they mention this path of partnership is not a fast path. If not fast, then why did they not rasie money during the suitable time, why now by taking their clotths off. Everybody will assume and understand they will spend all money, if rasied, to buy clotths and their butter. Why should people put money into the company that does not know if C14 is more capable than MM who took millions without any tangible delivery and trying to get the work done in less than a million? Will people give them money to stay paid to come again to ask for money to overcome insolvency? There should be an end of the d!rty gimmick of misleading people. Regulators should directly communicate with the C14 if C14 is at all capable to do anything. It looks like ASX should ask ASIC and ASIC should ask biotech agents. All expenses should be covered by the BoD and the CEO who have made millions by hiding information in the name of commercial in confidence.
- Forums
- ASX - By Stock
- Ann: Response to ASX Query Letter
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

Mate, plz stop promting the picture portrayed by the BIT...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $210 | 104.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 38848316 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 18281126 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
64 | 38848316 | 0.002 |
33 | 65631001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 18281126 | 25 |
0.004 | 12820969 | 17 |
0.005 | 6684000 | 5 |
0.006 | 1200000 | 2 |
0.007 | 1084188 | 2 |
Last trade - 12.28pm 27/06/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online